Surgical complications, disease progression, investigational product effects, or other medical causes
THEN Risk Impact MAY RESULT
Potential study hold or termination, as well as ethical and regulatory implications requiring immediate investigation and action
Risk Indicator
High Percentage of Subject Death
Metric
Percentage of Subjects Who Died
Unit
%
What level should be measured
Study, Country, Site
Purpose
This KRI ensures continuous oversight of participant safety and ethical trial conduct by identifying any elevated rate of subject deaths, enabling prompt corrective actions and safety reviews.
Description
This KRI tracks the proportion of deaths among randomized study participants. An unexpected increase may indicate underlying safety risks associated with the investigational product, procedures, or study design, warranting investigation and risk mitigation.
Formula
(Number of Randomized Subjects Who Died ÷ Total Number of Randomized Subjects) × 100%
Suggested Thresholds - High
0.1%
Suggested Thresholds - Medium
0.05%
Associated Metric 1
Number of Randomized Subjects
Associated Metric 2
Number of Randomized Subjects Who Died
Do you like the KRI description?Thanks for the feedbackThere was a problem submitting your feedback. Please try again later.